Kopran Limited , a prominent pharmaceutical company, has filed revised disclosures with stock exchanges regarding inter-family share transfers among its promoter group members. The company submitted these corrected filings on December 25, 2025, addressing incomplete details in earlier submissions.

Revised Disclosure Filing

The company received observations from BSE Limited regarding incomplete details in the original disclosures filed under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. The missing information included acquisition dates and equity share capital details. Following communication with the respective promoter group members, Kopran Limited received and submitted revised disclosures.

Key Share Transfer Transactions

The revised disclosures cover multiple inter-family transfers that occurred in September 2025:

Major Acquisitions

Share Disposals

Persons Acting in Concert

The transactions involve several entities acting in concert with the promoter group:

• Oriental Enterprises Partnership Firm (17,64,750 shares - 3.65%)
• Panorama Finvest Private Ltd. (38,00,000 shares - 7.87%)
• Parijat Shipping and Finale Limited (9,11,109 shares - 1.89%)
• Sarvamangal Mercantile Company Ltd. (29,02,951 shares - 6.01%)
• Oricon Enterprises Limited (62,17,183 shares - 12.88%)
• United Shippers Limited (22,00,000 shares - 4.56%)

Transaction Mode and Compliance

All transfers were executed through off-market transactions as inter-family transfers. The transactions remain exempt from open offer requirements under SEBI regulations, and all parties have committed to maintaining compliance with applicable disclosure requirements.

The revised filings provide complete transparency regarding the promoter group's shareholding restructuring, ensuring full regulatory compliance and accurate market disclosure.

Kopran Limited , a pharmaceutical company, has set September 4, 2025, as the record date for its upcoming dividend payment, subject to shareholder approval. The announcement comes as part of the company's preparations for its Annual General Meeting (AGM) scheduled for September 11, 2025.

Key Details

• Record Date: September 4, 2025
• AGM Date: September 11, 2025

Dividend Payment and Approval Process

The dividend payment is contingent upon approval by the company's shareholders at the upcoming AGM. If approved, the dividend will be subject to tax deduction at source, as per applicable regulations.

Regulatory Compliance

Kopran Limited has made this announcement in compliance with Regulation 42 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company has duly informed both the Bombay Stock Exchange (BSE) and the National Stock Exchange of India (NSE) about the record date and AGM details.

Company Information

Kopran Limited is headquartered at Parijat House, 1076, Dr. E. Moses Road, Worli, Mumbai - 400 018. The company's manufacturing facilities are located in Village Savroli, Taluka Khalapur, District Raigad - 410 202.

Investors and shareholders are advised to take note of the record date for dividend eligibility. The final decision on the dividend declaration will be made at the Annual General Meeting, where members will have the opportunity to vote on the proposal.

Shareholders and potential investors are encouraged to attend or follow the proceedings of the Annual General Meeting on September 11, 2025, for the final decision on the dividend payment and other important company matters.